Lack of mother-to-child HIV-1 transmission is associated with elevated serum levels of 90 K immune modulatory protein

被引:5
作者
Pelliccia, P
Galli, L
de Martino, M
Chiarelli, F
Verrotti, A
Sabatino, G
Fornarini, B
Iacobelli, S
Natoli, C
机构
[1] Univ Chieti, Dept Med, Div Paediat & Neonatol, Chieti, Italy
[2] Univ Florence, Dept Paediat, I-50121 Florence, Italy
[3] Univ Chieti, Dept Oncol & Neurosci, Sect Med Oncol, Chieti, Italy
关键词
HIV-1; mother-to-child HIV-1 transmission; 90; K; scavenger receptor cystein rich domain;
D O I
10.1097/00002030-200003100-00002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: 90 K is a secreted human serum glycoprotein with immune modulatory activity. Methods: Serum 90 K levels were determined by an enzyme-linked immunosorbent assay in 19 HIV-l-infected mothers at the time of delivery, in their new-borns (11 HIV-1 infected and eight uninfected), in 26 HIV-1-uninfected mothers and in 86 new-borns of HIV-1-uninfected mothers. Results: 90 K levels in HIV-l-infected transmissive mothers (22.4 +/- 13.9 mu g/ml) were similar to Those of HIV-1-uninfected mothers (21.1 +/- 7.6 mu g/ml; P = 0.715), but lower than those of HIV-1-infected non-transmissive mothers (45.5 +/- 24.8 mu g/ml; P = 0.019). The levels were higher in HIV-1-uninfected (47.6 +/- 22.4 mg/ml) than HIV 1-infected (23.7 +/- 15.6 mu g/ml; P = 0.014) new-borns of HIV-1-infected mothers. The new-borns of HIV-1-uninfected mothers had lower levels (11.7 +/- 5.3 mu g/ml) than both HIV-l-infected and HIV-1-uninfected new-horns of HIV-l-infected mothers (all differences, P < 0.001). Conclusion: These results suggest that high 90 K protein serum levels in HIV-1-infected mothers and their new-borns are associated with lack of mother-to-child HIV-1 transmission. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:F41 / F45
页数:5
相关论文
共 21 条
  • [1] Tumor-associated antigen 90K activates myelomonocytic cell line THP-1
    Altindag, ZZ
    Marth, C
    WernerFelmayer, G
    Natoli, C
    Zeimet, AG
    Wachter, H
    Iacobelli, S
    Fuchs, D
    [J]. CANCER LETTERS, 1996, 107 (01) : 143 - 148
  • [2] The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 -: A meta-analysis of 15 prospective cohort studies
    Andiman, W
    Boucher, M
    Burns, D
    Bryson, Y
    Farley, J
    Fowler, H
    Gabiano, C
    Galli, L
    Hutto, C
    Kind, C
    Korber, B
    Kovacs, A
    Krogstad, P
    Landesman, S
    Lapointe, N
    Lemay, M
    Lew, J
    Mandelbrot, L
    Mayaux, MJ
    Mellins, R
    Minkoff, H
    Mofenson, L
    Nielsen, K
    Newell, ML
    Pardi, G
    Peavy, H
    Peckham, C
    Read, J
    Rother, C
    Rudin, C
    Scott, G
    Semprini, A
    Shearer, W
    Simonds, R
    Simpson, B
    Stek, A
    Tovo, PA
    Tuomala, R
    Van Dyke, R
    Weedon, J
    de Martino, M
    Lindsay, M
    Belair, S
    Chan, L
    Harris, D
    Kalish, L
    Muenz, L
    Nugent, R
    Schluchter, M
    Durako, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (13) : 977 - 987
  • [3] [Anonymous], 1994, MMWR Recomm Rep, V43, P1
  • [4] [Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1
  • [5] Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients
    Artini, M
    Natoli, C
    Tinari, N
    Costanzo, A
    Marinelli, R
    Balsano, C
    Porcari, P
    Angelucci, D
    DEgidio, M
    Levrero, M
    Iacobelli, S
    [J]. JOURNAL OF HEPATOLOGY, 1996, 25 (02) : 212 - 217
  • [6] BARONDES SH, 1994, J BIOL CHEM, V269, P20807
  • [7] CHICHEPORTICHE Y, 1994, J BIOL CHEM, V269, P5512
  • [8] DEMARTINO M, 1994, LANCET, V343, P191
  • [9] 90K (Mac-2 BP) in human milk
    DOstilio, N
    Sabatino, G
    Natoli, C
    Ullrich, A
    Iacobelli, S
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 (03) : 543 - 546
  • [10] Fornarini B, 1999, CLIN EXP IMMUNOL, V115, P91